SCHEMBL324755

SCHEMBL324755

C=CCC1(N)N=CN=C2N=CN=C21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17744967 0.77
SCHEMBL31558393 0.74
SCHEMBL94056 0.71 MAOA (0.37)
SCHEMBL6897683 0.70
SCHEMBL8429764 0.69
SCHEMBL3321079 0.67
SCHEMBL7118357 0.67
SCHEMBL33790 0.67
SCHEMBL4551663 0.65
SCHEMBL6381754 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 640 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114807328-A Method for marking and identifying single-base resolution DNA 浙江大学 2022-07-29 CN claimed
US-8710023-B2 Antisense modulation of C-reactive protein expression ISIS PHARMACEUTICALS, INC. (US) 2014-04-29 US claimed
US-20140080894-A1 ENHANCED BIODISTRIBUTION OF OLIGOMERS GROOVE BIOPHARMA CORPORATION 2014-03-20 US claimed
WO-2013071079-A1 LIN28/LET-7 CRYSTAL STRUCTURES, PURIFICATION PROTOCOLS, AND MOLECULAR PROBES SUITABLE FOR SCREENING ASSAYS AND THERAPEUTICS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2013-05-16 WO claimed
WO-2012119051-A2 ENHANCED BIODISTRIBUTION OF OLIGOMERS GROOVE BIOPHARMA CORPORATION (US) 2012-09-07 WO claimed
US-20120077866-A1 ANTISENSE MODULATION OF C-REACTIVE PROTEIN EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 2012-03-29 US claimed
US-8093224-B2 Antisense modulation of C-reactive protein expression ISIS PHARMACEUTICALS, INC. (US) 2012-01-10 US claimed
US-20110117646-A1 ANTISENSE MODULATION OF C-REACTIVE PROTEIN EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 2011-05-19 US claimed
US-7915231-B2 Antisense modulation of C-reactive protein expression ISIS PHARMACEUTICALS, INC. (US) 2011-03-29 US claimed
US-20090275133-A1 ANTISENSE MODULATION OF C-REACTIVE PROTEIN EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 2009-11-05 US claimed
US-20060024727-A1 Antisense modulation of C-reactive protein expression ISIS PHARMACEUTICALS, INC. (US) 2006-02-02 US claimed
US-4050919-A TREATING WITH GIBBERELLIN AND CYCLIC 3',5'-ADENYLIC ACID KIKKOMAN SHOYU CO., LTD. (JA) 1977-09-27 US claimed
US-20240238210-A1 POLYNUCLEOTIDES ENCODING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR FOR THE TREATMENT OF CYSTIC FIBROSIS ARES CAPITAL CORPORATION, AS AGENT 2024-07-18 US disclosed
WO-2024151685-A1 RECOMBINANT NUCLEIC ACID MOLECULES AND THEIR USE IN WOUND HEALING BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) 2024-07-18 WO disclosed
WO-2024151687-A1 GENETIC SWITCHES AND THEIR USE IN TREATING CANCER FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2024-07-18 WO disclosed
WO-2024151673-A2 RECOMBINANT NUCLEIC ACID MOLECULES AND THEIR USE IN WOUND HEALING PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2024-07-18 WO disclosed
US-20030078324-A1 Containing nontoxic nucleic acid derivative flame retardant; for producing molded products MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. 2003-04-24 US disclosed
EP-1304352-A2 Polymer composition MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2003-04-23 EP disclosed
US-4342585-A TREATING THE FRUITS OR FLOWERS OF APPLES, TOMATOES OR STRAWBERRIES WITH CYCLIC-3', 5'-ADENYLIC ACID OR A-DERIVATIVE KIKKOMAN CORPORATION (JP) 1982-08-03 US disclosed
US-4050919-A TREATING WITH GIBBERELLIN AND CYCLIC 3',5'-ADENYLIC ACID KIKKOMAN SHOYU CO., LTD. (JA) 1977-09-27 US disclosed